RFK Jr. Overhauls Federal Autism Panel, Sparking Medical Community Backlash 
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease 
U.S. and Rwanda Sign $228 Million Health Partnership to Boost Self-Reliance 
Iran–U.S. Nuclear Talks in Oman Face Major Hurdles Amid Rising Regional Tensions 
UAE Plans Temporary Housing Complex for Displaced Palestinians in Southern Gaza 
Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan 
TrumpRx.gov Highlights GLP-1 Drug Discounts but Offers Limited Savings for Most Americans 
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss 
Trump Backs Review of U.S. Childhood Vaccine Schedule After Hepatitis B Policy Change 
New York Legalizes Medical Aid in Dying for Terminally Ill Patients 
Trump Rejects Putin’s New START Extension Offer, Raising Fears of a New Nuclear Arms Race 
Marco Rubio Steps Down as Acting U.S. Archivist Amid Federal Law Limits 
South Korea Assures U.S. on Trade Deal Commitments Amid Tariff Concerns 
China Warns US Arms Sales to Taiwan Could Disrupt Trump’s Planned Visit 
FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate 
U.S. President Donald Trump revealed on Saturday that his administration will deliver an important update on autism this Monday, sparking speculation about new health findings. Speaking at a dinner hosted by the conservative American Cornerstone Institute, Trump described it as “one of the most important things that we will do,” but declined to share details.
The Wall Street Journal recently reported that Health Secretary Robert F. Kennedy Jr. is preparing to announce potential risks tied to Tylenol, a popular pain reliever from Kenvue. According to the report, Kennedy may claim that using Tylenol during pregnancy could be linked to autism, a position that contradicts existing medical guidelines which deem the drug safe.
Autism diagnoses in the United States have climbed dramatically in recent decades, fueling ongoing debate. Data from the Centers for Disease Control and Prevention (CDC) shows that autism prevalence among 8-year-olds reached 1 in 36 in 2020 (2.77%), compared with 2.27% in 2018 and just 0.66% in 2000. Kennedy has repeatedly stated that America is facing an “autism epidemic” driven by environmental toxins, though most scientists argue the condition likely stems from a mix of genetics and environmental factors.
In addition to the autism update, Trump teased another policy rollout. He announced that Mehmet Oz, head of the Centers for Medicare and Medicaid Services, will unveil a “most favored nation” drug pricing model. This initiative aims to lower U.S. prescription drug costs by matching the lowest prices paid by other Organisation for Economic Co-operation and Development (OECD) countries. Trump emphasized that tariffs could be used against nations resisting fair pricing, calling Dr. Oz “a smart, tough guy” who could drive the plan forward.
